These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 15531511

  • 1. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
    Yildiz BO, Woods KS, Stanczyk F, Bartolucci A, Azziz R.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
    [Abstract] [Full Text] [Related]

  • 2. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 3. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N, Cetinozman F, Aksoy DY, Elcin G, Yildiz BO.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [Abstract] [Full Text] [Related]

  • 4. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R, Black VY, Knochenhauer ES, Hines GA, Boots LR.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [Abstract] [Full Text] [Related]

  • 5. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS.
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [Abstract] [Full Text] [Related]

  • 6. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
    Farah-Eways L, Reyna R, Knochenhauer ES, Bartolucci AA, Azziz R.
    Fertil Steril; 2004 Jan; 81(1):120-5. PubMed ID: 14711554
    [Abstract] [Full Text] [Related]

  • 7. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C, Reyna R, Boots LS, Azziz R.
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [Abstract] [Full Text] [Related]

  • 8. Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome.
    Carmina E, Gonzalez F, Chang L, Lobo RA.
    Obstet Gynecol; 1995 Jun; 85(6):971-6. PubMed ID: 7770269
    [Abstract] [Full Text] [Related]

  • 9. Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.
    Gambineri A, Forlani G, Munarini A, Tomassoni F, Cognigni GE, Ciampaglia W, Pagotto U, Walker BR, Pasquali R.
    J Endocrinol Invest; 2009 Mar; 32(3):210-8. PubMed ID: 19542736
    [Abstract] [Full Text] [Related]

  • 10. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 11. Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.
    Azziz R, Fox LM, Zacur HA, Parker CR, Boots LR.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2513-7. PubMed ID: 11397848
    [Abstract] [Full Text] [Related]

  • 12. DHEA, DHEAS and PCOS.
    Goodarzi MO, Carmina E, Azziz R.
    J Steroid Biochem Mol Biol; 2015 Jan; 145():213-25. PubMed ID: 25008465
    [Abstract] [Full Text] [Related]

  • 13. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
    Zhou R, Bird IM, Dumesic DA, Abbott DH.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
    [Abstract] [Full Text] [Related]

  • 14. Influence of insulin and testosterone on adrenocortical steroidogenesis in vitro: preliminary studies.
    Hines GA, Smith ER, Azziz R.
    Fertil Steril; 2001 Oct; 76(4):730-5. PubMed ID: 11591406
    [Abstract] [Full Text] [Related]

  • 15. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F, Chen M, Zhang W, Yin H, Chen G, Huang Q, Yang X, Chen L, Lin C, Yin G.
    J Ovarian Res; 2021 Feb 14; 14(1):32. PubMed ID: 33583431
    [Abstract] [Full Text] [Related]

  • 17. Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.
    Parker CR, Slayden SM, Azziz R, Crabbe SL, Hines GA, Boots LR, Bae S.
    J Clin Endocrinol Metab; 2000 Jan 14; 85(1):48-54. PubMed ID: 10634362
    [Abstract] [Full Text] [Related]

  • 18. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A.
    Eur J Endocrinol; 2002 Oct 14; 147(4):473-7. PubMed ID: 12370108
    [Abstract] [Full Text] [Related]

  • 19. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP, Geffner ME, Azziz R, Judd HL.
    Hum Reprod; 1997 Jun 14; 12(6):1138-41. PubMed ID: 9221990
    [Abstract] [Full Text] [Related]

  • 20. Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome.
    Kamel N, Tonyukuk V, Emral R, Corapçioğlu D, Baştemir M, Güllü S.
    Exp Clin Endocrinol Diabetes; 2005 Feb 14; 113(2):115-21. PubMed ID: 15772904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.